Insider Transactions in Q3 2021 at Cue Health Inc. (HLTH)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
John E Gallagher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
66,379
-12.08%
|
$1,194,822
$18.63 P/Share
|
|
Sep 28
2021
|
Cove Investors I, LLC |
BUY
Conversion of derivative security
|
Indirect |
6,721,714
+35.19%
|
-
|
|
Sep 28
2021
|
Section 32 Fund 2, LP |
BUY
Conversion of derivative security
|
Direct |
3,485,535
+50.0%
|
-
|
|
Sep 28
2021
|
Sherpa Ventures Fund, LP |
BUY
Other acquisition or disposition
|
Indirect |
371,293
+6.33%
|
$4,455,516
$12.8 P/Share
|
|
Sep 28
2021
|
Sherpa Ventures Fund, LP |
BUY
Conversion of derivative security
|
Indirect |
14,545,868
+49.35%
|
-
|
|
Sep 28
2021
|
Scott Stanford |
BUY
Grant, award, or other acquisition
|
Indirect |
371,293
+6.33%
|
$4,455,516
$12.8 P/Share
|
|
Sep 28
2021
|
Scott Stanford |
BUY
Conversion of derivative security
|
Indirect |
14,545,868
+49.35%
|
-
|
|
Sep 28
2021
|
Xiangmin Cui |
BUY
Grant, award, or other acquisition
|
Indirect |
788,441
+50.0%
|
$9,461,292
$12.8 P/Share
|
|
Sep 28
2021
|
Xiangmin Cui |
BUY
Conversion of derivative security
|
Indirect |
8,192,468
+50.0%
|
-
|
|
Sep 28
2021
|
Decheng Capital China Life Sciences Usd Fund Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
8,192,468
+50.0%
|
-
|
|
Sep 28
2021
|
Christopher K Achar Director |
BUY
Conversion of derivative security
|
Direct |
69,710
+4.56%
|
-
|
|
Sep 24
2021
|
Clint Sever Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
798,636
+18.27%
|
-
|
|
Sep 24
2021
|
K Joanne Bradford Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Sep 24
2021
|
Ayub K Khattak President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
976,111
+7.77%
|
-
|
|
Sep 24
2021
|
Maria Martinez Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Sep 24
2021
|
Carole T Faig Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Sep 24
2021
|
Christopher K Achar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,388,246
+50.0%
|
-
|